FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Carlos Ferreira

Research Profile

Chemicals & Drugs

Disorders

Anatomy

Co-author Network

Publications

TOP 3
Elisa Giovannetti; Harold H J Backus; Dorine Wouters; Carlos G Ferreira; Viola M M van Houten; Ruud H Brakenhoff; M-F Poupon; A Azzarello; HERBERT PINEDO; Godefridus J Peters
Changes in the status of p53 affect drug sensitivity to thymidylate synthase (TS) inhibitors by altering TS levels.
Agnieszka Checinska; Giuseppe Giaccone; Bas S J Hoogeland; Carlos G Ferreira; Jose A Rodriguez; Frank A E Kruyt
TUCAN/CARDINAL/CARD8 and apoptosis resistance in non-small cell lung cancer cells.
Frank A E Kruyt; Agnieszka Checinska; Giuseppe Giaccone; Carlos G Ferreira
Correspondence re: L. Yang et al., Predominant suppression of apoptosome by inhibitor of apoptosis protein in non-small cell lung cancer H460 cells: therapeutic effect of a novel polyarginine-conjugated Smac peptide. Cancer Res., 63: 831-837, 2003.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Carlos Ferreira (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Elisa Giovannetti; Harold H J Backus; Dorine Wouters; Carlos G Ferreira; Viola M M van Houten; Ruud H Brakenhoff; M-F Poupon; A Azzarello; HERBERT PINEDO; Godefridus J Peters
Changes in the status of p53 affect drug sensitivity to thymidylate synthase (TS) inhibitors by altering TS levels.
British journal of cancer 2007;96(5):769-75.
2006: Agnieszka Checinska; Giuseppe Giaccone; Bas S J Hoogeland; Carlos G Ferreira; Jose A Rodriguez; Frank A E Kruyt
TUCAN/CARDINAL/CARD8 and apoptosis resistance in non-small cell lung cancer cells.
BMC cancer 2006;6():166.
2003: Frank A E Kruyt; Agnieszka Checinska; Giuseppe Giaccone; Carlos G Ferreira
Correspondence re: L. Yang et al., Predominant suppression of apoptosome by inhibitor of apoptosis protein in non-small cell lung cancer H460 cells: therapeutic effect of a novel polyarginine-conjugated Smac peptide. Cancer Res., 63: 831-837, 2003.
Cancer research 2003;63(19):6566-7; author reply 6568.
2003: Miriam Ferrer; Thijs Izeboud; Carlos G Ferreira; Simone W Span; Giuseppe Giaccone; Frank A E Kruyt
Cisplatin triggers apoptotic or nonapoptotic cell death in Fanconi anemia lymphoblasts in a concentration-dependent manner.
Experimental cell research 2003;286(2):381-95.
2003: Harold H J Backus; Dorine Wouters; Carlos G Ferreira; Viola M M van Houten; Ruud H Brakenhoff; HERBERT PINEDO; Godefridus J Peters
Thymidylate synthase inhibition triggers apoptosis via caspases-8 and -9 in both wild-type and mutant p53 colon cancer cell lines.
European journal of cancer (Oxford, England : 1990) 2003;39(9):1310-7.
2002: Linda E Bröker; Cynthia Huisman; Carlos G Ferreira; Jose A Rodriguez; Frank A E Kruyt; Giuseppe Giaccone
Late activation of apoptotic pathways plays a negligible role in mediating the cytotoxic effects of discodermolide and epothilone B in non-small cell lung cancer cells.
Cancer research 2002;62(14):4081-8.
2002: Carlos G Ferreira; Mirjam Epping; Frank A E Kruyt; Giuseppe Giaccone
Apoptosis: target of cancer therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(7):2024-34.
2002: Jose A Rodríguez; Simone W Span; Carlos G Ferreira; Frank A E Kruyt; Giuseppe Giaccone
CRM1-mediated nuclear export determines the cytoplasmic localization of the antiapoptotic protein Survivin.
Experimental cell research 2002;275(1):44-53.
2002: Cynthia Huisman; Carlos G Ferreira; Linda E Bröker; Jose A Rodriguez; Egbert F Smit; Pieter E Postmus; Frank A E Kruyt; Giuseppe Giaccone
Paclitaxel triggers cell death primarily via caspase-independent routes in the non-small cell lung cancer cell line NCI-H460.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(2):596-606.
2002: Carlos G Ferreira; Cynthia Huisman; Giuseppe Giaccone
Novel approaches to the treatment of non-small cell lung cancer.
Critical reviews in oncology/hematology 2002;41(1):57-77.
2001: Carlos G Ferreira; Paul Van Der Valk; Simone W Span; Irene S Ludwig; Egbert F Smit; Frank A E Kruyt; HERBERT PINEDO; Harm van Tinteren; Giuseppe Giaccone
Expression of X-linked inhibitor of apoptosis as a novel prognostic marker in radically resected non-small cell lung cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(8):2468-74.
2001: Carlos G Ferreira; Paul Van Der Valk; Simone W Span; J M Jonker; Pieter E Postmus; Frank A E Kruyt; Giuseppe Giaccone
Assessment of IAP (inhibitor of apoptosis) proteins as predictors of response to chemotherapy in advanced non-small-cell lung cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(6):799-805.
2000: Carlos G Ferreira; Simone W Span; Godefridus J Peters; Frank A E Kruyt; Giuseppe Giaccone
Chemotherapy triggers apoptosis in a caspase-8-dependent and mitochondria-controlled manner in the non-small cell lung cancer cell line NCI-H460.
Cancer research 2000;60(24):7133-41.
2000: Carlos G Ferreira; C Tolis; Simone W Span; Godefridus J Peters; T van Lopik; A J Kummer; HERBERT PINEDO; Giuseppe Giaccone
Drug-induced apoptosis in lung cnacer cells is not mediated by the Fas/FasL (CD95/APO1) signaling pathway.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(1):203-12.
1999: Carlos G Ferreira; C Tolis; Giuseppe Giaccone
p53 and chemosensitivity.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(9):1011-21.
1999: C Tolis; Godefridus J Peters; Carlos G Ferreira; HERBERT PINEDO; Giuseppe Giaccone
Cell cycle disturbances and apoptosis induced by topotecan and gemcitabine on human lung cancer cell lines.
European journal of cancer (Oxford, England : 1990) 1999;35(5):796-807.